Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market. More
LT-NS001, is an NSAID pro-drug for the treatment of chronic inflammatory conditions, such as osteoarthritis. Multiple phase I trials demonstrated its safety and proof of concept. More
Collagen-based biodegradable matrices for localized drug delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2010 - 121 pages - $3,835
Jun 2006 - 952 pages - $2,495
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Apr 2008 - 52 pages - $1,995
Nov 2011 - 7 pages - $75
Jun 2010 - 64 pages - $5,700
Dec 2010 - 37 pages - $5,700
Dec 2010 - 62 pages - $5,700
Sep 2007 - 18 pages - $1,695
Your selection
Browse By
- Therapeutic target
- Accident & Trauma (other)
- Back Pain
- Bone fractures
- Burns
- CNS trauma
- Drug overdose
- Hemorraghic trauma
- Muscle sprain/strain
- Poisioning
- Reperfusion injury (lung/heart)
- Stroke/traumatic brain injury
- Tissue grafting
- Wound closure/surgical adhesive
- Wound/ulcer healing
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us